TRiCares is a medical device company with global offices that designs and develops specialized structural heart treatments and catheter-based valve repair systems.
Subscribe to see Tricares’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tricares is a medical devices company headquartered in France. Its most recent funding round, Series D, raised $50M in July 2024. Xcout tracks 5 named people at Tricares, including Ahmed Elmouelhi (President & Chief Executive Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $50M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Tricares's closest competitors — see the full list of competitors and alternatives →
Coramaze Technologies is a clinical and pre-commercial stage medical device company founded in 2013, with offices in Germany and Israel. The company is focused on developing an innovative transcatheter tricuspid valve repair system called TriPair.
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
Polares Medical is a medical device company headquartered in Palo Alto, California, developing novel medical devices and structural heart technologies.
CroiValve is a Dublin-based medical technology company focused on developing minimally invasive heart valve devices, such as the DUO System, to treat tricuspid regurgitation.
HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.
Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.